• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Cureus . Miller-Fisher Syndrome Following Influenza A Infection

tetano

Editor, Senior Moderator
Cureus


. 2024 Mar 12;16(3):e56064.
doi: 10.7759/cureus.56064. eCollection 2024 Mar. Miller-Fisher Syndrome Following Influenza A Infection

Shiho Mitsuhashi[SUP] 1 [/SUP], Asuka Suzuki[SUP] 1 [/SUP], Koji Hayashi[SUP] 1 [/SUP], Mamiko Sato[SUP] 1 [/SUP], Yuka Nakaya[SUP] 1 [/SUP], Naoko Takaku[SUP] 1 [/SUP], Yasutaka Kobayashi[SUP] 2 [/SUP]



Affiliations
Abstract

Miller-Fisher syndrome (MFS), characterized by ophthalmoplegia, ataxia, and areflexia, is a Guillain-Barré syndrome (GBS) variant. It is well-known that the causative antibody for MFS is anti-GQ1b antibody. This report describes a rare case of MFS with not only anti-GQ1b antibodies but also anti-GT1a antibodies following Influenza A infection. The patient, a 47-year-old woman, contracted Influenza A three weeks before admission. She complained of double vision followed by areflexia, ataxia in the four extremities, and complete gaze palsy. She was treated with intravenous methylprednisolone pulse and intravenous immunoglobulin therapies. Her neurological symptoms were recovered after these immunotherapies.

Keywords: guillain-barre syndrome (gbs); influenza virus type a; intravenous immunoglobulins (ivig); methyl prednisolone; miller fisher syndrome (mfs).

 
Back
Top Bottom